Alzheimer’s Disease International (ADI) has launched the Alzheimer’s Disease Atlas (AD Atlas), a first of its kind platform highlighting how countries diagnose, treat and support people living with dementia. The platform brings together the key indicators needed to assess a country’s preparedness for Alzheimer’s disease and related dementias, helping advocates, policymakers and healthcare leaders identify where people are being left behind. The AD Atlas, supported by Eli Lilly and Company, shows that people living with dementia can face very different experiences of diagnosis, care and support depending on where they…
Read MoreNew Global Alzheimer’s Disease Country Insights Tool Reveals Major Inequalities In Diagnosis, Treatment Access And Preparedness Across Countries
